Klinikum Der Landeshauptstadt Stuttgart gKAöR — Clinical Trial Site

87 Registered trials

55 Currently recruiting

Organisation

Klinikum Der Landeshauptstadt Stuttgart gKAöR

Location

Stuttgart, Germany

Identifier

ORG-100009355

Address

Kriegsbergstrasse 62, Mitte, 70174, Germany

Departments

#1201: Pädiatrie 5 (Onkologie, Hämatologie, Immunologie)
2102: Klinik für Nuklearmedizin
Augenklinik, Kopf- und Neurozentrum
Clinic for Haematology, Oncology, Stem Cell Transplantation and Palliative Medicine
Clinic for Hematology, Oncology, Stem Cell Transplantation and Palliative Medicine
Clinic for Kidney, Hypertension and Autoimmune Diseases
Department of Radiation and Oncology
Fachabteilungsbereich Hämatologie und internistische Onkologie
Frauenklinik
Gynecology and Obstetrics
Hämatologie, Onkologie und Palliativmedizin
Hämatologie,Onkologie, Palliativmedizin
Hämatologie/Onkologie
Hämostaseologie und Stammzelltransplantation
Hematology
Interdisziplinäre internistische Onkologie, Hämatologie und Palliativmedizin
Katharinenhospital, Klinik für Hämatologie, Onkologie, Stammzelltransplantation und Palliativmedizin
Kinder und Jugendmedizin
Klinik f. Hämatologie, Onkologie u. Palliativmedizin
Klinik fuer Urologie
Klinik für Endokrinologie, Diabetologie und Geriatrie
Klinik für Gastroenterologie, gastrointestinale Onkologie, Hepatologie, Infektiologie u. Pneumologie
Klinik für Hämatologie, Onkologie und Palliativmedizin
Klinik für Hämatologie, Onkologie und Palliativmedizin Stuttgart Cancer Center
Klinik für Hämatologie, Onkologie und Palliativmedizin Stuttgart Cancer Center/Tumorzentrum Eva Ma
Klinik für Hämatologie, Onkologie und Palliativmedizin, Stuttgart Cancer Center
Klinik für Hämatologie, Onkologie, Stammzelltransplantation und Palliativmedizin
Klinik für Hämatologie, Onkologie, Stammzelltransplantation und Palliativmedizin
Klinik für Hämatologie, Onkologie, Stuttgart Cancer Center (SCC)
Klinik für Neurologie
Klinik für Onkologie
Klinik für Pneumologie und Beatmungsmedizin
Klinik für Pneumologie und Beatmungstherapie
Klinik für Strahlentherapie und Radioonkologie
Klinik für Urologie und Transplantationschirurgie
Klinikum Stuttgart - Katharinenhospital, Innere Medizin
Neurologische Klinik
Olgahospital Pädiatrie 5
Olgahospital, Pädiatrie 5 (Onkologie, Hämatologie, Immunologie)
Olgasptial / Frauenklinik
Oncology Department
Oncology, Hematology and Immunology
Ophthalmology
Pädiatrie 5
Pädiatrie 5 (Onkologie, Hämatologie und Immunologie)
Pädiatrie 5 (Onkologie, Hämatologie, Immunologie)
Paediatrie3–ZentrumfuerAngeboreneHerzfehlerStuttgart,PaediatrischeIntensivmedizin,Pneumologie,Allerg
Paedriatrics, Department of Oncology and Hematology
Pediatric hematology/oncology
Pediatrics 5 (hematology, oncology, immunology)
Strahlentherapie und Radioonkologie
Stuttgart Cancer Center Mitte
Stuttgart Cancer Center Standort Mitte (Katharinenhospital)
Stuttgart Cancer Center, Tumorzentrum Eva-Mayr-Stihl
Tumorzentrum Eva Mayr-Stihl
Tumorzentrum Eva-Mayr-Stihl
Urologische Klinik
Zentrum fuer Dermatologie, Phlebologie und Allergologie
Zentrum für Kinder- und Jugendmedizin
Zentrum für Kinder- und Jugendmedizin Pädiatrie 5 (Onkologie, Hämatologie, Immunologie)
Zentrum für Kinder-, Jugend und Frauenmedizin Pädiatrie 5 (Onkologie, Hämatologie; Immunologie)
Zentrum für Kinder-, Jugend- und Frauenmedizin

Clinical trials at this site (87)

Search interface

International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma Recruiting

2022-501180-40-00 Ewing Sarcoma 5 2022-06-17
Post-resection/ ablation chemotherapy in patients with metastatic colorectal cancer (FIRE-9 - PORT / AIO-KRK-0418). Prospective, randomized,… Recruiting

2024-512174-10-00 metastatic colorectal cancer 5 2021-11-11
SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years. Recruiting

2024-510578-25-00 Histologically proven high-risk medulloblastoma, with a 5 2021-11-05
FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting

2024-510579-40-00 Rhabdoyosarcoma 9 2020-10-07
FOLFOX before surgey compared to risk-adapted chemotherapy after surgery in patients with locally advanced rectal cancer and low risk for lo… Recruiting

2024-518077-34-00 locally advanced rectal cancer 5 2020-09-30
International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the effica… Recruiting

2022-501454-11-00 standard risk ALK-positive anaplastic large cell lympho 5 2020-02-05
SIOP RANDOMET 2017 Recruiting

2023-508926-91-00 Stage IV childhood renal tumour with pulmonary +/- non- 5 2019-12-05
LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma Recruiting

2023-508101-24-00 Lymphoblastic lymphoma 5 2019-08-01
Paediatric Hepatic International Tumour Trial Recruiting

2024-516110-38-00 Hepatoblastoma and Hepatocellular Carcinoma 5 2018-03-06
SIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependym… Recruiting

2024-512222-28-00 Newly diagnosed with an intracranial or spinal ependymo 10 2015-06-02
Phase 2 Study of Adjuvant V940 and Pembrolizumab in Renal Cell Carcinoma Ended

2023-505177-32-00 Intermediate-high -risk RCC, high-risk RCC who have und 4 2024-07-31
MTR² Ended

2022-502790-42-00 Primary Central Nervous Lymphoma (PCNSL) 4 2024-06-24
Individualized Immunotherapy in Early-Stage Unfavorable Classical Hodgkin Lymphoma Ended

2022-500571-32-00 Early-Stage Unfavorable Classical Hodgkin Lymphoma 4 2024-05-15
A study to compare the study treatment darolutamide in combination with androgen deprivation therapy (ADT) to placebo in combination with AD… Ended

2022-501343-33-00 Biochemically recurrent prostate cancer 5 2023-10-18
A Study to Comparing the Efficacy and Safety of Glofitamab (RO7082859) in Combination with Polatuzumab Vedotin Plus Rituximab, Cyclophospha… Ended

2023-504028-24-00 Large B-Cell Lymphoma 5 2023-09-22
ANTELOPE – Atezolizumab/Carboplatin/nab-Paclitaxel vs. Pembrolizumab/Platinum/Pemetrexed in metastatic TTF-1 negative lung adenocarcinoma Ended

2023-505054-17-00 metastatic TTF-1 negative lung adenocarcinoma 6 2023-09-15
A study to test BI 765179 alone and in combination with ezabenlimab in patients with advanced cancer (solid tumors) and BI 765179 in combina… Ended

2023-510307-22-00 Advanced head and neck cancer 1 2021-09-24
Optimizing MATRix, a combination of Methotrexate, Ara-C, Thiotepa and Rituximab given as an induction therapy, de-escalated in duration and … Ended

2024-514473-21-00 Primary diffuse large B-cell lymphoma (DLBCL) of the ce 5 2021-06-21
A phase II trial investigating Gemcitabine/Oxaliplatin/Rituximab with Tafasitamab (MOR208) for patients aggressive Lymphoma. Ended

2024-514775-17-00 Malignant B-cell lymphoma 4 2021-02-10
Short course radiotherapy versus chemoradiotherapy, followed by consolidation chemotherapy, and selective organ preservation for MRI-defined… Ended

2024-511577-29-01 intermediate and high-risk rectal cancer 5 2020-03-13
RADIANCE Radiochemotherapy +/- Durvalumab for locally-advanced Anal Carcinoma A multicenter, randomized, phase II trial of the German Anal C… Ended

2024-513914-36-00 locally-advanced Anal Carcinoma, Anal cancer stage II a 4 2019-12-17
Randomized Phase III Study of Standard Intensive Chemotherapy versus Intensive Chemotherapy with CPX-351 in Adult Patients with Newly Diagno… Ended

2023-503670-21-00 Patients with newly diagnosed AML and intermediate- or 5 2019-08-28
Comparison of Carboplatin and Cisplatin in patients with extracranial malignant germ cell tumours Ended

2023-507582-25-00 Malignant Extracranial Germ Cell Tumours (MGCT) 5 2019-08-02
Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystecto… Ended

2023-504932-16-00 Muscle Invasive Bladder Cancer 5 2019-06-04